CVR number 31370213
Industry 85.5900 Other education n.e.c.

CARDIAC CONSULT ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.3% 1.3% 1.3% 1.3% 1.3%  
Bankruptcy risk  2.3% 1.1% 0.8% 0.7% 4.5%  
Credit score (0-100)  66 83 90 93 46  
Credit rating  BBB A AA AA BBB  
Credit limit (kDKK)  0.1 352.2 801.3 1,056.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  587 2,397 3,861 3,071 -197  
EBITDA  5.6 1,975 3,441 2,651 -452  
EBIT  -243 1,754 3,042 2,253 -832  
Pre-tax profit (PTP)  -253.0 6,010.9 3,777.0 2,203.1 -885.5  
Net earnings  -565.3 4,989.0 2,855.0 1,614.8 -837.6  
Pre-tax profit without non-rec. items  -253 6,011 3,777 2,203 -886  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  4,521 7,777 7,393 6,995 6,868  
Shareholders equity total  5,989 7,978 7,333 8,948 7,860  
Interest-bearing liabilities  0.0 3,057 2,953 2,849 2,746  
Balance sheet total (assets)  6,390 12,469 11,861 12,731 10,826  
Net Debt  -1,603 -1,160 2,260 136 1,760  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  587 2,397 3,861 3,071 -197  
Gross profit growth  -19.3% 308.4% 61.1% -20.5% 0.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  6,390 12,469 11,861 12,731 10,826  
Balance sheet change%  -10.0% 95.1% -4.9% 7.3% -15.0%  
Added value  5.6 1,975.2 3,441.3 2,652.4 -451.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -236 3,035 -783 -797 -507  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 2.0 3.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -41.4% 73.2% 78.8% 73.3% 422.7%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -3.6% 64.1% 31.7% 18.3% -7.1%  
ROI %  -3.8% 70.9% 36.1% 20.4% -7.4%  
ROE %  -8.8% 71.4% 37.3% 19.8% -10.0%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  93.7% 64.0% 61.8% 70.3% 72.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -28,485.0% -58.7% 65.7% 5.1% -389.6%  
Gearing %  0.0% 38.3% 40.3% 31.8% 34.9%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 2.3% 2.4% 1.7% 1.9%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  4.9 3.0 0.9 2.7 3.1  
Current Ratio  4.9 3.0 0.9 2.7 3.1  
Cash and cash equivalent  1,602.8 4,216.8 693.4 2,712.9 985.3  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,491.7 3,150.0 -151.6 1,758.2 694.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  6 1,975 3,441 2,652 -452  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  6 1,975 3,441 2,651 -452  
EBIT / employee  -243 1,754 3,042 2,253 -832  
Net earnings / employee  -565 4,989 2,855 1,615 -838